Market Cap 3.34B
Revenue (ttm) 445.76M
Net Income (ttm) 24.14M
EPS (ttm) N/A
PE Ratio 38.43
Forward PE 48.34
Profit Margin 5.42%
Debt to Equity Ratio 0.00
Volume 1,021,800
Avg Vol 951,626
Day's Range N/A - N/A
Shares Out 79.05M
Stochastic %K 41%
Beta 2.16
Analysts Strong Sell
Price Target $44.00

Company Profile

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It is also developing the nCounter analysis system services. The company...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 650 243 6300
Fax: 650 243 6388
Address:
6000 Shoreline Court, Suite 300, South San Francisco, United States
PrivateProfiteer
PrivateProfiteer Nov. 14 at 5:00 AM
$VCYT is currently trading at $39.87, with an RSI of 57.52 indicating a neutral to slightly bullish momentum. The price is above the 30-day moving average (MA30) of 37.11 and the 50-day moving average (MA50) of 35.48, suggesting a positive trend in the short to medium term. The recent 60-day high of 46.44 provides a key resistance level, while the 60-day low of 28.25 offers support. Directional bias is bullish due to the price being above both MAs and the RSI indicating room for further upside before reaching overbought conditions. Suggested entry point is around $40.00. Set a stop loss at $37.50 to manage risk. Target 1 is $44.00, just below the recent high, and Target 2 is $46.00, aiming for a breakout above the 60D high. Monitor market conditions closely, as volatility (ATR of 2.36) may affect price movement. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 3:07 AM
$VCYT is currently trading at $42.66, showing a strong upward trend with a 60-day high of $46.44 and a low of $28.25. The RSI at 69.71 indicates that the stock is nearing overbought territory, suggesting caution for potential pullbacks. The 30-day moving average (MA30) at $36.77 and the 50-day moving average (MA50) at $35.08 provide solid support levels, indicating a bullish trend as the price is significantly above these averages. Given the current market context, the directional bias leans bullish, but the high RSI suggests a possible short-term correction. A suggested entry point could be around $41.50, with a stop loss set at $40.00 to manage risk. For targets, consider $44.00 as an initial target and $46.00 as a secondary target, aligning with the recent high. Overall, monitor for a potential pullback before entering to optimize entry price. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 2:42 AM
$VCYT is currently trading at $42.66, showing a strong upward trend with a 60-day high of $46.44 and a low of $28.25. The RSI at 69.71 indicates that the stock is nearing overbought territory, suggesting caution for potential pullbacks. The 30-day moving average (MA30) at $36.77 and the 50-day moving average (MA50) at $35.08 provide solid support levels, indicating a bullish trend as the price is significantly above these averages. Given the current market context, the directional bias leans bullish, but the high RSI suggests a possible short-term correction. A suggested entry point could be around $41.50, with a stop loss set at $40.00 to manage risk. For targets, consider $44.00 as an initial target and $46.00 as a secondary target, aligning with the recent high. Overall, monitor for a potential pullback before entering to optimize entry price. https://privateprofiteers.com
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 11 at 9:14 PM
11/07 to 11/21 $VCYT $VCEL $VB $VAL $UYG
0 · Reply
JarvisFlow
JarvisFlow Nov. 11 at 4:59 PM
Morgan Stanley has adjusted their stance on Veracyte ( $VCYT ), setting the rating to Underweight with a target price of 28 → 40.
0 · Reply
ZacksResearch
ZacksResearch Nov. 11 at 1:24 PM
$VCYT just crushed Q3 earnings — why this stock is soaring! 🚀 📈 EPS jumped 54.5% from the year-ago period, beating estimates by 59.4% 💰 Q3 revenue up 13.8% year over year, outpacing forecasts by 5.5% 🔝 Shares soared 27.5% post-earnings Find out what’s driving this breakout 👉 https://www.zacks.com/stock/news/2789079/vcyt-stock-gains-on-q3-earnings-and-revenue-beat-25-view-up?cid=sm-stocktwits-2-2789079-body-20394&ADID=SYND_STOCKTWITS_TWEET_2_2789079_BODY_20394
0 · Reply
ZacksResearch
ZacksResearch Nov. 11 at 12:24 PM
$VCYT surges after crushing Q3 expectations — is this just the start? 🚀 Earnings and revenue both beat estimates, fueled by strong growth in Decipher and Afirma test volumes. Full breakdown of Veracyte’s Q3 momentum and upgraded 2025 outlook here 👉 https://www.zacks.com/stock/news/2789079/vcyt-stock-gains-on-q3-earnings-and-revenue-beat-25-view-up?cid=sm-stocktwits-2-2789079-teaser-20393&ADID=SYND_STOCKTWITS_TWEET_2_2789079_TEASER_20393
0 · Reply
HodlMaBeer
HodlMaBeer Nov. 6 at 1:42 PM
$VCYT decent position in wife's name
0 · Reply
DanaBlack
DanaBlack Nov. 6 at 4:10 AM
$VCYT overnight
0 · Reply
PhishTourFunds
PhishTourFunds Nov. 5 at 11:11 PM
$VCYT 100% winner at this point
0 · Reply
Latest News on VCYT
Veracyte to Participate in Upcoming Investor Conferences

Nov 6, 2025, 8:30 AM EST - 8 days ago

Veracyte to Participate in Upcoming Investor Conferences


Veracyte, Inc. (VCYT) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 11:46 PM EST - 9 days ago

Veracyte, Inc. (VCYT) Q3 2025 Earnings Call Transcript


Veracyte Announces Third Quarter 2025 Financial Results

Nov 4, 2025, 4:05 PM EST - 10 days ago

Veracyte Announces Third Quarter 2025 Financial Results


Veracyte: Q2 Earnings Brings My Position Out Of Mothballs

Aug 26, 2025, 10:18 AM EDT - 2 months ago

Veracyte: Q2 Earnings Brings My Position Out Of Mothballs


Veracyte, Inc. (VCYT) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 2:20 AM EDT - 3 months ago

Veracyte, Inc. (VCYT) Q2 2025 Earnings Call Transcript


Veracyte Announces Second Quarter 2025 Financial Results

Aug 6, 2025, 4:05 PM EDT - 3 months ago

Veracyte Announces Second Quarter 2025 Financial Results


Veracyte, Inc. (VCYT) Q1 2025 Earnings Call Transcript

May 8, 2025, 12:49 AM EDT - 6 months ago

Veracyte, Inc. (VCYT) Q1 2025 Earnings Call Transcript


Veracyte Announces First Quarter 2025 Financial Results

May 7, 2025, 4:05 PM EDT - 6 months ago

Veracyte Announces First Quarter 2025 Financial Results


Solid Growth, Soft Outlook: Why I'm Holding On Veracyte

Feb 25, 2025, 10:32 AM EST - 9 months ago

Solid Growth, Soft Outlook: Why I'm Holding On Veracyte


Veracyte, Inc. (VCYT) Q4 2024 Earnings Call Transcript

Feb 24, 2025, 10:53 PM EST - 9 months ago

Veracyte, Inc. (VCYT) Q4 2024 Earnings Call Transcript


Veracyte, Inc. (VCYT) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 10:49 PM EST - 1 year ago

Veracyte, Inc. (VCYT) Q3 2024 Earnings Call Transcript


Veracyte Announces Third Quarter 2024 Financial Results

Nov 6, 2024, 4:05 PM EST - 1 year ago

Veracyte Announces Third Quarter 2024 Financial Results


Veracyte, Inc. (VCYT) Q2 2024 Earnings Call Transcript

Aug 6, 2024, 10:17 PM EDT - 1 year ago

Veracyte, Inc. (VCYT) Q2 2024 Earnings Call Transcript


Veracyte Announces Second Quarter 2024 Financial Results

Aug 6, 2024, 4:05 PM EDT - 1 year ago

Veracyte Announces Second Quarter 2024 Financial Results


Veracyte Announces First Quarter 2024 Financial Results

May 7, 2024, 4:05 PM EDT - 1 year ago

Veracyte Announces First Quarter 2024 Financial Results


PrivateProfiteer
PrivateProfiteer Nov. 14 at 5:00 AM
$VCYT is currently trading at $39.87, with an RSI of 57.52 indicating a neutral to slightly bullish momentum. The price is above the 30-day moving average (MA30) of 37.11 and the 50-day moving average (MA50) of 35.48, suggesting a positive trend in the short to medium term. The recent 60-day high of 46.44 provides a key resistance level, while the 60-day low of 28.25 offers support. Directional bias is bullish due to the price being above both MAs and the RSI indicating room for further upside before reaching overbought conditions. Suggested entry point is around $40.00. Set a stop loss at $37.50 to manage risk. Target 1 is $44.00, just below the recent high, and Target 2 is $46.00, aiming for a breakout above the 60D high. Monitor market conditions closely, as volatility (ATR of 2.36) may affect price movement. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 3:07 AM
$VCYT is currently trading at $42.66, showing a strong upward trend with a 60-day high of $46.44 and a low of $28.25. The RSI at 69.71 indicates that the stock is nearing overbought territory, suggesting caution for potential pullbacks. The 30-day moving average (MA30) at $36.77 and the 50-day moving average (MA50) at $35.08 provide solid support levels, indicating a bullish trend as the price is significantly above these averages. Given the current market context, the directional bias leans bullish, but the high RSI suggests a possible short-term correction. A suggested entry point could be around $41.50, with a stop loss set at $40.00 to manage risk. For targets, consider $44.00 as an initial target and $46.00 as a secondary target, aligning with the recent high. Overall, monitor for a potential pullback before entering to optimize entry price. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 2:42 AM
$VCYT is currently trading at $42.66, showing a strong upward trend with a 60-day high of $46.44 and a low of $28.25. The RSI at 69.71 indicates that the stock is nearing overbought territory, suggesting caution for potential pullbacks. The 30-day moving average (MA30) at $36.77 and the 50-day moving average (MA50) at $35.08 provide solid support levels, indicating a bullish trend as the price is significantly above these averages. Given the current market context, the directional bias leans bullish, but the high RSI suggests a possible short-term correction. A suggested entry point could be around $41.50, with a stop loss set at $40.00 to manage risk. For targets, consider $44.00 as an initial target and $46.00 as a secondary target, aligning with the recent high. Overall, monitor for a potential pullback before entering to optimize entry price. https://privateprofiteers.com
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 11 at 9:14 PM
11/07 to 11/21 $VCYT $VCEL $VB $VAL $UYG
0 · Reply
JarvisFlow
JarvisFlow Nov. 11 at 4:59 PM
Morgan Stanley has adjusted their stance on Veracyte ( $VCYT ), setting the rating to Underweight with a target price of 28 → 40.
0 · Reply
ZacksResearch
ZacksResearch Nov. 11 at 1:24 PM
$VCYT just crushed Q3 earnings — why this stock is soaring! 🚀 📈 EPS jumped 54.5% from the year-ago period, beating estimates by 59.4% 💰 Q3 revenue up 13.8% year over year, outpacing forecasts by 5.5% 🔝 Shares soared 27.5% post-earnings Find out what’s driving this breakout 👉 https://www.zacks.com/stock/news/2789079/vcyt-stock-gains-on-q3-earnings-and-revenue-beat-25-view-up?cid=sm-stocktwits-2-2789079-body-20394&ADID=SYND_STOCKTWITS_TWEET_2_2789079_BODY_20394
0 · Reply
ZacksResearch
ZacksResearch Nov. 11 at 12:24 PM
$VCYT surges after crushing Q3 expectations — is this just the start? 🚀 Earnings and revenue both beat estimates, fueled by strong growth in Decipher and Afirma test volumes. Full breakdown of Veracyte’s Q3 momentum and upgraded 2025 outlook here 👉 https://www.zacks.com/stock/news/2789079/vcyt-stock-gains-on-q3-earnings-and-revenue-beat-25-view-up?cid=sm-stocktwits-2-2789079-teaser-20393&ADID=SYND_STOCKTWITS_TWEET_2_2789079_TEASER_20393
0 · Reply
HodlMaBeer
HodlMaBeer Nov. 6 at 1:42 PM
$VCYT decent position in wife's name
0 · Reply
DanaBlack
DanaBlack Nov. 6 at 4:10 AM
$VCYT overnight
0 · Reply
PhishTourFunds
PhishTourFunds Nov. 5 at 11:11 PM
$VCYT 100% winner at this point
0 · Reply
PhishTourFunds
PhishTourFunds Nov. 5 at 11:10 PM
0 · Reply
JarvisFlow
JarvisFlow Nov. 5 at 11:08 PM
UBS has updated their rating for Veracyte ( $VCYT ) to Buy with a price target of 48.
0 · Reply
HodlMaBeer
HodlMaBeer Nov. 5 at 10:50 PM
$VCYT lovely!!! totally missed this
0 · Reply
G101SPM
G101SPM Nov. 5 at 8:36 PM
CORRECTION $VCYT $45.78 +9.76. SELL/TAKE PROFITS ON 20% of long position to reduce net cost. DAC (dollar average cost includes this partial SELL) (5) $21.14 . EXIT $65.00
0 · Reply
G101SPM
G101SPM Nov. 5 at 8:28 PM
$VCYT $45.78 +9.76. SELL/TAKE FROMS ON 20% of long position to reduce net cost. DAC (dollar average cost includes this partial SELL) $21.14 Holding long position https://stocktwits.com/G101SPM/message/622414619 CHANGE EXIT TO $65.00 (midterm) FROM $35.00.
0 · Reply
Llain1
Llain1 Nov. 5 at 7:44 PM
$VCYT nice, thanks veracyte I’m out for now x
0 · Reply
DanaBlack
DanaBlack Nov. 5 at 6:51 PM
$VCYT 🚀🚀🚀
0 · Reply
JarvisFlow
JarvisFlow Nov. 5 at 6:37 PM
Canaccord Genuity updates rating for Veracyte ( $VCYT ) to Hold, target set at 40 → 43.
0 · Reply
JarvisFlow
JarvisFlow Nov. 5 at 3:05 PM
Guggenheim updates rating for Veracyte ( $VCYT ) to Buy, target set at 40 → 45.
0 · Reply
JarvisFlow
JarvisFlow Nov. 5 at 11:02 AM
Needham has updated their rating for Veracyte ( $VCYT ) to Buy with a price target of 44.
0 · Reply
PhishTourFunds
PhishTourFunds Oct. 31 at 10:11 PM
$VCYT Accumulating
0 · Reply
Following_the_trend
Following_the_trend Oct. 22 at 6:43 PM
$VCYT small add today
0 · Reply